Immune-based therapy is in its infancy and to date no therapies are licensed in Australia. A number of the reagents are reaching phase III clinical trials and may be available within two years. Patient and physician interest is high because antiretroviral agents have not as yet had a significant impact on survival.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
immune-based therapy
8
managing hiv
4
hiv primary
4
primary therapy
4
therapy immune-based
4
therapy hiv
4
hiv infection
4
infection immune-based
4
therapy infancy
4
infancy therapies
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!